Use of phenylalanine lactate for the preparation of a medicament for distinguishing between healthy people and hypertensive patients and for improving blood pressure in hypertensive patients
By using lactate phenylalanine as a biomarker and combining it with mass spectrometry to detect metabolites in biological samples, the problem of distinguishing between healthy people and hypertensive patients has been solved. Lactate phenylalanine drugs have been developed, which significantly improve blood pressure in hypertensive patients, achieving rapid and sensitive detection and treatment effects.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BEIJING INST OF HEART LUNG & BLOOD VESSEL DISEASES
- Filing Date
- 2025-11-19
- Publication Date
- 2026-07-24
AI Technical Summary
Current technologies lack effective biomarkers to distinguish between healthy individuals and hypertensive patients, and there is a lack of drugs that can significantly improve blood pressure in hypertensive patients.
Using lactate phenylalanine as a biomarker, the levels of metabolites in biological samples were detected by mass spectrometry. The working characteristic curve was used to distinguish between healthy people and hypertensive patients. Lactate phenylalanine drugs were developed to improve hypertension. The content of multiple metabolites was detected by liquid chromatography-tandem mass spectrometry.
It enables rapid and sensitive differentiation between healthy individuals and hypertensive patients, significantly reduces blood pressure in hypertensive patients, provides a new drug for the treatment of hypertension, and the detection method is simple and efficient.
Smart Images

Figure CN121577894B_ABST
Abstract
Citation Information
Patent Citations
US20230296622A1